As published in Behavioural Pharmacology, two days of PT00114 treatment reduced corticosterone levels and attenuated anxiety-like behavior in chronically stressed rats; a known CRF₁ receptor ...
A US electronic health record study found that adults with obesity who started semaglutide or tirzepatide had lower recorded ...
Morning Overview on MSN
Low testosterone in older men was tied to a leading cause of vision loss
Older men whose testosterone levels drop or are medically suppressed face a measurably higher risk of age-related macular ...
Morning Overview on MSN
A Moderna mRNA flu shot won a unanimous FDA panel nod for older adults
Older adults who face the highest rates of flu hospitalization moved one step closer to a new vaccine option on June 18, 2026 ...
School-based programmes may prevent adolescents from starting to use electronic cigarettes (e-cigarettes) and a community-based programme delivered by text message probably helps adolescents quit ...
Many of the FDA’s decisions this quarter involve applications that have previously been delayed, declined or outright ...
Cannabinoid therapies may alleviate agitation in Alzheimer disease, though somnolence remains a primary safety concern.
Candel Therapeutics (CADL) shifts to late-stage oncology with CAN-2409 Phase III wins and BLA catalyst. Read here for a ...
Glasgow Times on MSN
Update on development plans for Union Street fire site
Plans are being drawn up to have the Union Street fire site in use before Christmas this year.
Cefazolin demonstrated equivalent survival rates and lower kidney injury risks compared to standard antistaphylococcal penicillins in a new trial.
Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”), a pharmaceutical company focused on developing new medicines for vector-borne disease, announced today that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results